Literature DB >> 2412557

Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients.

E Theodorsson-Norheim, I Norheim, K Oberg, E Brodin, J M Lundberg, K Tatemoto, P G Lindgren.   

Abstract

Evidence is presented for the presence of an entire family of tachykinin-immunoreactive peptides in plasma and tumor tissues from patients with carcinoid tumors. The peptides include in addition to substance P and neurokinin A; neurokinin B, an eledoisin like peptide and neuropeptide K--a 36 amino acid long tachykinin which contains neurokinin A at its C-terminus. Neuropeptide K seems to be the tachykinin which is present in highest concentrations in plasma as well as in acetic acid extracts of tumor tissues. It is highly biologically active, and may therefore contribute to the clinical symptoms of carcinoid tumors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412557     DOI: 10.1016/0006-291x(85)91772-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 2.  Tubulovillous adenoma of the duodenum: a new etiology for flushing and urinary 5-HIAA elevation.

Authors:  S A Betchen; M Cirigliano; E E Furth; D Broussard; M Grippi; G R Lichtenstein
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

3.  Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea-pig--evidence for extraneuronal cleavage of neuropeptide K to neurokinin A.

Authors:  C R Martling; E Theodorsson-Norheim; I Norheim; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

4.  Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival.

Authors:  I Norheim; K Oberg; E Theodorsson-Norheim; P G Lindgren; G Lundqvist; A Magnusson; L Wide; E Wilander
Journal:  Ann Surg       Date:  1987-08       Impact factor: 12.969

5.  Angiotensin-converting enzyme inhibition, cough and the serum concentration of substance P.

Authors:  H Thysell; K E Andersson; S I Andersson; R Ekman
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  An experimental study of the neurogenic and the immunological contribution to "tennis elbow" in rats.

Authors:  E Haker; E Theodorsson; T Lundeberg
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

7.  Neuropeptide K potently stimulates salivary gland secretion and potentiates substance P-induced salivation.

Authors:  Y Takeda; J E Krause
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

8.  What is the cause of the carcinoid flush?

Authors:  D G Grahame-Smith
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

9.  HCl-stimulated duodenal HCO3- secretion in conscious rat. Interactions among VIP, nicotinic receptor mechanisms, and prostaglandins.

Authors:  B Smedfors; E Theodorsson; C Johansson
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

10.  Use of somatostatin analog in management of carcinoid syndrome.

Authors:  A Vinik; A R Moattari
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.